Completed OBSERVATIONAL NCT04776811

Evaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis

Sponsor: Elaine Chow

Conditions Diabetes Mellitus (Diagnosis) Dialysis End Stage Renal Disease

Interventions Continuous glucose monitoring system

Updated 5 times since 2021 Last updated: Nov 24, 2022 Started: Mar 1, 2021 Primary completion: Sep 30, 2022 Completion: Sep 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes Mellitus (Diagnosis) and Dialysis, this trial is completed. The trial is conducted by Elaine Chow and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Sep 2021 — Dec 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Apr 2021 — Sep 2021 [monthly]

Not Yet Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Elaine Chow
Medtronic Diabetes

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, China